Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases.

[1]  S. Raychaudhuri.  Role of IL-17 in Psoriasis and Psoriatic Arthritis , 2013, Clinical Reviews in Allergy & Immunology.

[2]  G. Szücs,et al.  Malignancies associated with systemic sclerosis. , 2012, Autoimmunity reviews.

[3]  S. Carrasco,et al.  Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis. , 2012, Autoimmunity reviews.

[4]  M. Diaz-Zamudio,et al.  Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study , 2012, Rheumatology International.

[5]  S. Gay,et al.  Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? , 2012, Autoimmunity reviews.

[6]  D. Jewell,et al.  The IL-23/IL-17 pathway in inflammatory bowel disease , 2012, Expert review of gastroenterology & hepatology.

[7]  R. Ransohoff,et al.  Re-establishing immunological self-tolerance in autoimmune disease , 2012, Nature Medicine.

[8]  Weiping Zou,et al.  Deciphering the role of Th17 cells in human disease. , 2011, Trends in immunology.

[9]  S. Sakaguchi,et al.  Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions. , 2011, Seminars in immunology.

[10]  C. Piccirillo,et al.  Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I diabetes. , 2011, Autoimmunity reviews.

[11]  Z. Amoura,et al.  Human FoxP3+ regulatory T cells in systemic autoimmune diseases. , 2011, Autoimmunity reviews.

[12]  C. Vasconcelos,et al.  Systemic sclerosis refractory disease: from the skin to the heart. , 2011, Autoimmunity reviews.

[13]  J. O’Shea,et al.  T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. , 2011, Trends in immunology.

[14]  R. Giacomelli,et al.  Cellular players in angiogenesis during the course of systemic sclerosis. , 2011, Autoimmunity reviews.

[15]  R. Giacomelli,et al.  Angiogenic cytokines and growth factors in systemic sclerosis. , 2011, Autoimmunity reviews.

[16]  M. Coenen,et al.  Deciphering the genetic background of systemic sclerosis , 2011, Expert review of clinical immunology.

[17]  S. Negrini,et al.  Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis. , 2011, Clinical immunology.

[18]  P. Szodoray,et al.  Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis , 2011, Scandinavian journal of rheumatology.

[19]  T. Wynn,et al.  Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[20]  A. Kimura,et al.  Th17 cells in inflammation. , 2011, International immunopharmacology.

[21]  Yuhong Yang,et al.  Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? , 2011, Biochimica et biophysica acta.

[22]  G. Filaci,et al.  CD8+ T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity , 2011, Autoimmunity.

[23]  M. Gershwin,et al.  Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis. , 2010, Journal of autoimmunity.

[24]  A. Kimura,et al.  IL‐6: Regulator of Treg/Th17 balance , 2010, European journal of immunology.

[25]  C. Selmi,et al.  Update on primary biliary cirrhosis. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[26]  C. De Simone,et al.  Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea , 2010, The British journal of dermatology.

[27]  J. Rosenbloom,et al.  Narrative Review: Fibrotic Diseases: Cellular and Molecular Mechanisms and Novel Therapies , 2010, Annals of Internal Medicine.

[28]  M. Mayes,et al.  Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations , 2009, Arthritis research & therapy.

[29]  K. Isse,et al.  Periductal interleukin‐17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis , 2009, Clinical and experimental immunology.

[30]  R. Simms,et al.  Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSc) Is Related to a Diminished CD69 and TGFβ Expression , 2009, PloS one.

[31]  R. Lafyatis,et al.  The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGFβ and IFNγ Distinguishes SSc Phenotypes , 2009, PloS one.

[32]  T. Jiang,et al.  Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population , 2009, Clinical and experimental immunology.

[33]  Laura Conti,et al.  T‐helper 17 cells expand in multiple sclerosis and are inhibited by interferon‐β , 2009, Annals of neurology.

[34]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[35]  K. Tsuneyama,et al.  Hepatic IL-17 responses in human and murine primary biliary cirrhosis. , 2009, Journal of autoimmunity.

[36]  Chen Dong,et al.  CCR6 Regulates the Migration of Inflammatory and Regulatory T Cells1 , 2008, The Journal of Immunology.

[37]  D. Olive,et al.  Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells. , 2008, Human immunology.

[38]  M. Gershwin,et al.  The immunobiology of systemic sclerosis. , 2008, Seminars in arthritis and rheumatism.

[39]  David E. Anderson,et al.  IL-21 and TGF-β are required for differentiation of human TH17 cells , 2008, Nature.

[40]  M. Fujimoto,et al.  Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease? , 2008, Journal of dermatological science.

[41]  S. Chevalier,et al.  Chronically Inflamed Human Tissues Are Infiltrated by Highly Differentiated Th17 Lymphocytes , 2008, The Journal of Immunology.

[42]  E. Barillot,et al.  A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses , 2008, Nature Immunology.

[43]  D. Littman,et al.  The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt , 2008, Nature Immunology.

[44]  Robert W. Williams,et al.  Interleukin 17–producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice , 2008, Nature Immunology.

[45]  T. Wynn,et al.  Cellular and molecular mechanisms of fibrosis , 2008, The Journal of pathology.

[46]  P. Hillsamer,et al.  Human Th17 Cells Share Major Trafficking Receptors with Both Polarized Effector T Cells and FOXP3+ Regulatory T Cells1 , 2008, The Journal of Immunology.

[47]  Pietro Invernizzi,et al.  Autophagy: highlighting a novel player in the autoimmunity scenario. , 2007, Journal of autoimmunity.

[48]  D. Levy,et al.  IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways , 2007, Nature Immunology.

[49]  D. Jarrossay,et al.  Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.

[50]  P. Invernizzi,et al.  Interpreting serological tests in diagnosing autoimmune liver diseases. , 2007, Seminars in liver disease.

[51]  B. Kahaleh,et al.  Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. , 2006, Arthritis and rheumatism.

[52]  J. Węsierska‐Gądek,et al.  Antinuclear antibodies in primary biliary cirrhosis. , 2005, Seminars in liver disease.

[53]  R. Fiocca,et al.  Non‐Antigen‐Specific CD8+ T Suppressor Lymphocytes in Diseases Characterized by Chronic Immune Responses and Inflammation , 2005, Annals of the New York Academy of Sciences.

[54]  C. Selmi,et al.  The enigma of primary biliary cirrhosis , 2005, Clinical reviews in allergy & immunology.

[55]  F. Sampogna,et al.  Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement , 2004, Clinical and experimental immunology.

[56]  Simon C Watkins,et al.  Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts. , 2004, The Journal of rheumatology.

[57]  D. Olive,et al.  Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. , 2004, Human immunology.

[58]  N. Suciu-Foca,et al.  CD8+ T suppressor cells are back to the game: are they players in autoimmunity? , 2002, Autoimmunity reviews.

[59]  D. Abraham,et al.  Transforming growth factor-&bgr; and connective tissue growth factor: key cytokines in scleroderma pathogenesis , 2001, Current opinion in rheumatology.

[60]  G. Filaci,et al.  Impairment of CD8+ T Suppressor Cell Function in Patients with Active Systemic Lupus Erythematosus1 , 2001, The Journal of Immunology.

[61]  K. Takabayashi,et al.  Increased interleukin-17 production in patients with systemic sclerosis. , 2000, Arthritis and rheumatism.

[62]  Kazuhide Yamamoto,et al.  Cytokine Profile in the Liver of Primary Biliary Cirrhosis , 1999, Journal of Clinical Immunology.

[63]  H. Ihn,et al.  Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis. , 1999, Rheumatology.

[64]  L. Steinman,et al.  CD4+ T-cell subsets in autoimmunity. , 1997, Current opinion in immunology.

[65]  B. Berman,et al.  Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. , 1991, The Journal of investigative dermatology.

[66]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[67]  I. Mackay,et al.  Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. , 1987, Journal of immunology.

[68]  Jia Newcombe,et al.  Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. , 2008, The American journal of pathology.

[69]  David E. Anderson,et al.  OR.41. IL-21 and TGF-β are Required for Differentiation of Human Th17 Cells , 2008 .

[70]  K. Bost,et al.  Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis. , 1994, Autoimmunity.

[71]  R. Strieter,et al.  In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. , 1993, Pathobiology : journal of immunopathology, molecular and cellular biology.

[72]  F. Wigley,et al.  Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma. , 1992, Arthritis and rheumatism.

[73]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.